Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice

(2012) Lixiang Wang et al.   ANNALS OF NEUROLOGY

Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura

(2012) F. Callewaert et al.   BLOOD

The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy

(2012) Marie-Catherine Rouzaud et al.   THROMBOSIS AND HAEMOSTASIS

ADAMTS13 exerts a thrombolytic effect in microcirculation

(2012) Melanie Demers et al.   THROMBOSIS AND HAEMOSTASIS

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

(2011) H. Ulrichts et al.   BLOOD

Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review

(2011) M. C. VAN SCHIE et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

von Willebrand Factor

(2011) Simon F. De Meyer et al.   STROKE

Binding of von Willebrand Factor to Collagen and Glycoprotein Ibα, But Not to Glycoprotein IIb/IIIa, Contributes to Ischemic Stroke in Mice—Brief Report

(2010) Simon F. De Meyer et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Antithrombotic drugs in coronary artery disease: risk benefit ratio and bleeding

(2010) S. SCHULMAN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Plasma levels of von Willebrand factor in the etiologic subtypes of ischemic stroke

(2010) E. HANSON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

High von Willebrand Factor Levels Increase the Risk of Stroke

(2010) Renske G. Wieberdink et al.   STROKE

von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke

(2009) B.-Q. Zhao et al.   BLOOD

ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion

(2009) M. Fujioka et al.   BLOOD

Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo

(2009) Stefania Momi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

The molecular basis of thrombolysis and its clinical application in stroke

(2009) V. Murray et al.   JOURNAL OF INTERNAL MEDICINE

Dynamics of platelet thrombus formation

(2009) S. P. JACKSON et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A new case of acquired Glanzmann's thrombasthenia: Diagnostic value of flow cytometry

(2008) S. Giannini et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Antiplatelet Therapy for Secondary Prevention of Noncardioembolic Ischemic Stroke

(2008) Martin J. O’Donnell et al.   STROKE

Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stroke: Results of an International Phase III Trial

(2007) Harold P. Adams et al.   STROKE